Charles Rouse, MD
Clinical Cardiac Electrophysiology · Bridgeport, CTNPI 1528383536
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $17,925 of the $28,273 with a category attached, or 63.4%. 22 manufacturers reported payments, led by Biosense Webster, Inc. at 38.4% of the total.
Across 303 payments — averaging $93.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biosense Webster, Inc.$11K
- Medical Device Business Services, Inc.$10K
- Abbott$5K
- Boston Scientific$492
- Biotronik Inc.$460
- Medtronic$219
- plus $1K from 16 others
Across 20 payments — averaging $60,384 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$998K
- Eli Lilly$209K
What the payments were for
- Consulting fees$17,92563%
- Travel & lodging$4,14515%
- Food & beverage$6,20222%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biosense Webster, Inc. | 179 | $10,857 |
| Medical Device Business Services, Inc. | 9 | $9,825 |
| Abbott | 37 | $5,210 |
| Boston Scientific | 13 | $492 |
| Biotronik Inc. | 6 | $460 |
| Medtronic(2 entities) | 6 | $219 |
| Amgen | 7 | $187 |
| Genentech USA, Inc. | 1 | $139 |
| E.r. Squibb & Sons, L.L.C. | 7 | $117 |
| Regeneron Healthcare Solutions, Inc. | 5 | $116 |
| Johnson & Johnson | 6 | $99 |
| Boehringer Ingelheim | 4 | $74 |
| Novartis | 3 | $67 |
| Amarin Pharma, Inc. | 3 | $66 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 3 | $61 |
| Kowa Pharmaceuticals America, Inc. | 4 | $59 |
| AstraZeneca | 3 | $56 |
| Pfizer | 2 | $45 |
| Sanofi-aventis U.S. LLC | 2 | $38 |
| Impulse Dynamics (USA) Inc. | 1 | $37 |
| Cardiva Medical, Inc. | 1 | $29 |
| Alnylam Pharmaceuticals Inc. | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Carto 3$18,373
- AVEIR$3,939
- Assurity Pacemaker$187
- EnSite Precision Cardiac Mapping System$138
- Micra$120
- Acticor 7 VR-T DX$119
How this compares
$28,273 in reported general payments places this provider in the 60th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.
See all clinical cardiac electrophysiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 63 | $78,599 |
| EntrestoSacubitril/Valsartan | 17 | $20,464 |
| Metoprolol Succinate | 101 | $1,302 |
| Flecainide Acetate | 19 | $854 |
| Torsemide | 18 | $500 |
| Amiodarone Hcl | 53 | $441 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 20 | $304 |
| Furosemide | 48 | $254 |
| Losartan Potassium | 28 | $251 |
| Atorvastatin Calcium | 26 | $216 |
| Valsartan | 13 | $207 |
| Rosuvastatin Calcium | 19 | $206 |
| Metoprolol Tartrate | 16 | $86 |
| Amlodipine Besylate | 24 | $75 |
| Spironolactone | 14 | $64 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $45 | $78,59963 claims |
| NovartisEntresto | $67 | $20,46417 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.
Other clinical cardiac electrophysiology in Bridgeport
- Craig McPhersonBridgeport$17K
- Joseph Dell OrfanoHartford$160K
- Paras BhattNorwich$139K
- Steven ZweibelHartford$125K
- Murali ChiravuriFairfield$101K
- James FreemanNew Haven$87K
- Jude ClancyMiddletown$84K
- Joseph TianoTrumbull$70K
- Michael PittaroStamford$70K
- Neal LippmanHartford$69K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.